These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 8573219)
1. Identification of efonidipine hydrochloride metabolites in rats. Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219 [TBL] [Abstract][Full Text] [Related]
2. Plasma and urinary metabolites of efonidipine hydrochloride in man. Nakabeppu H; Asada M; Oda T; Shinozaki Y; Yajima T Xenobiotica; 1996 Feb; 26(2):229-39. PubMed ID: 8868006 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs. Takayama F; Iwasawa Y; Saito K; Shiratori K; Ohtawa M Xenobiotica; 1989 Dec; 19(12):1407-20. PubMed ID: 2618091 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs. Hirota T; Nakamura A; Sugihara K; Morino A Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man. Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788 [TBL] [Abstract][Full Text] [Related]
7. Biotransformation of amlodipine. Identification and synthesis of metabolites found in rat, dog and human urine/confirmation of structures by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. Beresford AP; Macrae PV; Alker D; Kobylecki RJ Arzneimittelforschung; 1989 Feb; 39(2):201-9. PubMed ID: 2525041 [TBL] [Abstract][Full Text] [Related]
8. Identification of benidipine hydrochloride metabolites in rats and dogs. Kobayashi H; Okumura S; Kosaka Y; Kobayashi S; Inoue A; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1753-6. PubMed ID: 3219155 [TBL] [Abstract][Full Text] [Related]
9. Biotransformation of nifedipine in rat and dog. Scherling D; Karl W; Radtke M; Ahr HJ; Siefert HM Arzneimittelforschung; 1992 Nov; 42(11):1292-300. PubMed ID: 1492841 [TBL] [Abstract][Full Text] [Related]
10. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist. Yabuki M; Shono F; Nakatsuka I; Yoshitake A Drug Metab Dispos; 1993; 21(6):1167-9. PubMed ID: 7905400 [No Abstract] [Full Text] [Related]
11. In Vitro-In Vivo Correlation for Solid Dispersion of a Poorly Water-Soluble Drug Efonidipine Hydrochloride. Cheng X; Gao J; Li J; Cheng G; Zou M; Piao H AAPS PharmSciTech; 2020 May; 21(5):160. PubMed ID: 32476084 [TBL] [Abstract][Full Text] [Related]
12. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
13. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress. Morimoto S; Jo F; Maki K; Iwasaka T Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462 [TBL] [Abstract][Full Text] [Related]
14. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance. Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742 [TBL] [Abstract][Full Text] [Related]
15. Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method. Huang S; Zhang Q; Li H; Sun Y; Cheng G; Zou M; Piao H Eur J Pharm Biopharm; 2018 Sep; 130():108-114. PubMed ID: 29928981 [TBL] [Abstract][Full Text] [Related]
16. Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment. Otsuka M; Maeno Y; Fukami T; Inoue M; Tagami T; Ozeki T Eur J Pharm Biopharm; 2016 Nov; 108():25-31. PubMed ID: 27553261 [TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys. Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672 [TBL] [Abstract][Full Text] [Related]
18. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats. Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932 [TBL] [Abstract][Full Text] [Related]
19. Determination of efonidipine in human plasma by LC-MS/MS for pharmacokinetic applications. Liu M; Zhao H; Tong Y; Zhang D; Wang X; Zhang L; Han J; Liu H J Pharm Biomed Anal; 2015 Jan; 103():1-6. PubMed ID: 25462114 [TBL] [Abstract][Full Text] [Related]
20. Identification of new metabolites of morroniside produced by rat intestinal bacteria and HPLC-PDA analysis of metabolites in vivo. Li X; Huo C; Wang Q; Zhang X; Sheng X; Zhang L J Pharm Biomed Anal; 2007 Oct; 45(2):268-74. PubMed ID: 17707607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]